The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

Also called NCT02407548

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02407548
Other papers using this trial's data
  • Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals Journal of clinical lipidology, 2018 DOI, PubMed 29454678

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02407548. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (actual); primary completion 2017-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia
Acronym
TEDSCD
Condition
Dyslipidemia
Intervention (Dietary supplement)
coenzyme Q10 vitamin E softgel
Intervention (Dietary supplement)
coenzyme Q10 softgel
Intervention (Dietary supplement)
placebo softgel
Lead sponsor
Sun Yat-sen University (class: other)

Record details

Record id
cardio:ct-nct02407548
Content hash
af572ba1fb8050050c1ad55bf6c24143e2643a884819c368f76cde3de2949521